Back to results
US 11,993,658 B2Granted
Anti-BCMA antibodies and treatment methods
AssigneeSutro Biopharma, Inc.
InventorsAlice Yam, Ryan Stafford, Xiaofan Li, Junhao Yang, Stephanie Armstrong, Abigail Yu
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to antibodies that selectively bind to B-cell maturation antigen (BCMA) and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
Claims16
An isolated antibody of the IgG class that specifically binds to B-cell maturation antigen (BCMA), wherein the antibody comprises a CDR-H1, a CDR-H2, a CDR-H3, a CDR-LI, a CDR-L2, and a CDR-L3, of the VH-VL (heavy chain variable region-light chain variable region) pair of SEQ ID NO:
- 170 and 217.
Dependencies are inferred from the claim text.